Post

New research · Obstetrics & Gynecology
Acta obstetricia et gynecologica Scandinavica · 1d
Cohort studyActa obstetricia et gynecologica Scandinavica · 2026

Loss to follow-up in patients diagnosed with or treated for low- and high-grade squamous intraepithelial lesions: A comparison of general practitioner- and gynecologist-led surveillance.

Lieke van de Kam, Albert Siebers, Ruud Bekkers … Jurgen Piek
Read paper
Obstetrics & GynecologyCohort study

General practitioner follow-up for low-grade squamous intraepithelial lesions linked to higher loss.

Loss to follow-up in patients diagnosed with or treated for low- and high-grade squamous intraepithelial lesions: A comparison of general practitioner- and gynecologist-led surveillance.

Lieke van de Kam et al. · Acta obstetricia et gynecologica Scandinavica · 2026
Background

Cervical carcinoma can be prevented by treating precancerous lesions, which are classified as low-grade (LSIL) and high-grade (HSIL) squamous intraepithelial lesions.

Methods

This retrospective cohort study included patients diagnosed with LSIL or treated HSIL by the gynecologist, with no prior history of SIL or cervical cancer, who either underwent cytological follow-up at the gynecologist or the general practitioner.

38.1%
Results
patients with low-grade precancerous cervical lesions missing family doctor follow-up
More results

A total of 691 patients were followed up by the gynecologist, and 1172 by the general practitioner.

For treated HSIL, 44.3% (132/298) were lost to follow-up at 24 months in the general practitioner group, versus 24.1% (33/137) in the gynecologist group (p < 0.001).

“
Conclusion

Follow-up by a general practitioner after a diagnosis of LSIL or treated HSIL is associated with nearly twice the rate of loss to follow-up compared to follow-up by a gynecologist.

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
Randomized Trial
-2.3 percentage points
the chance of staying cancer-free for 3 years was higher with biopsy only
Randomized Trial
HR 0·42
for p53-abnormal tumors, combined treatment nearly halved the risk of cancer returning
Cohort Study
HR 0.85
The hazard of death was similar with adjuvant chemoradiotherapy versus radiotherapy alone.
Cohort Study
95.3%
adding abdominal fat thickness improved the correct identification of gestational diabetes
Cohort Study
26.4%
women with diabetes during pregnancy developed high blood pressure 5 months after birth
Cohort Study
HR, 0.81
hormone therapy was associated with a better chance of living longer
Cohort Study
33.3%
Among pregnant women with anemia, a higher percentage had babies born early
Randomized Trial
3.8% vs 27.5%
fewer patients experienced delayed bowel function after surgery with milk of magnesia